GENERIC NAME OF MEDICINAL PRODUCT:

A. Citicoline Injection IP 500mg/2ml
B. Citicoline Injection IP 1000mg/4ml

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Citicoline Injection IP 500mg/2ml
Each ml contains:
Citicoline Sodium IP
Equivalent to Citicoline……250mg
Water for Injection IP……….q.s

B. Citicoline Injection IP 1000mg/4ml
Each ml contains:
Citicoline Sodium IP
Equivalent to Citicoline……250mg
Water for Injection IP……….q.s


THERAPEUTIC INDICATION:

Citicoline is taken by mouth or given as an injection to help memory loss due to aging, improve vision in people with glaucoma, and help with recovery in stroke patients. It is also used for Alzheimer disease, Parkinson disease, bipolar disorder, lazy eye, and other conditions of the brain.

DIRECTION OF USE:

For Intramuscular or Intravenous use only.
See enclosed leaflet for further information.

CAUTION AND SCHEDULE:

CAUTION: Do not use if solution is not clear or has visible particulate matter.
DO NOT ACCEPT IF VIAL SEAL IS BROKEN.
Discard unused portion.
Should not to be used in patients with hypersensitivity.
Should not be used in pregnant or lactating women.
KEEP OUT OF REACH AND SIGHT OF CHILDREN.
SCHEDULE: SCHEDULE 'H PRESCRIPTION DRUG-CAUTION Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE AND DOSAGE:

STORAGE: Store below 25℃.
Protect from light.
Store in a cool, dry and dark place.
DOSAGE: As directed by the Neurologist/Specialist.

Citicoline Injection IP 1000mg/4ml Technical Specification:

Product Name:Citicoline Injection IP
Brand Name:Generic
Strength:500mg/2ml,    1000mg/4ml
Dosage Form:Liquid Injection
Packing:250mg/1ml (2ml, 4ml Ampoules)
Route of Administration:For I.M./I.V. use only
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Product Permission, Stability Studies, GMP
Therapeutic use:Psychostimulant/Nootropic
Indication: Citicoline is taken by mouth or given as an injection to help memory loss due to aging, improve vision in people with glaucoma, and help with recovery in stroke patients. It is also used for Alzheimer disease, Parkinson disease, bipolar disorder, lazy eye, and other conditions of the brain.
Storage:Store in a cool, dry and dark place. Protect from light.

GENERIC NAME OF MEDICINAL PRODUCT:

  • Citicoline Injection IP 1000mg/4ml

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Citicoline Injection IP 1000mg/4ml
    Each ml contains:
    Citicoline Sodium IP
    Equivalent to Citicoline……250mg
    Water for Injection IP……….q.s

THERAPEUTIC INDICATION:

Citicoline is taken by mouth or given as an injection to help memory loss due to aging, improve vision in people with glaucoma, and help with recovery in stroke patients. It is also used for Alzheimer disease, Parkinson disease, bipolar disorder, lazy eye, and other conditions of the brain.

DIRECTION OF USE:

For Intramuscular or Intravenous use only.
See enclosed leaflet for further information.

CAUTION AND SCHEDULE:

CAUTION: Do not use if solution is not clear or has visible particulate matter.
DO NOT ACCEPT IF VIAL SEAL IS BROKEN.
Discard unused portion.
Should not to be used in patients with hypersensitivity.
Should not be used in pregnant or lactating women.
KEEP OUT OF REACH AND SIGHT OF CHILDREN.

SCHEDULE: SCHEDULE ‘H PRESCRIPTION DRUG-CAUTION Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE AND DOSAGE:

STORAGE: Store below 25℃.
Protect from light.
Store in a cool, dry and dark place.

DOSAGE: As directed by the Neurologist/Specialist.